Institution
National Medical Products Administration
Recent research
- Health & MedicineOpen access
CXCR4-targeted dual softener for inducing senescence therapy in hepatic fibrosis
Hepatic fibrosis is a central pathological driver of chronic liver diseases, including metabolic dysfunction-associated steatotic liver disease and alcohol-related liver disease, which collectively impose a growing global health burden. Fibrosis is primarily mediated by persisten...
- Materials & Energy
Identification of Impurities in Norvancomycin Hydrochloride Drug Substance Using UHPLC‐QTOF‐MS
ABSTRACT Rationale Norvancomycin (NVCM) hydrochloride belongs to a group of glycopeptide antibiotics and exhibits strong effects against Gram‐positive cocci and bacilli. The safety of patients' lives is directly related to the quality of drugs. The impurities play often an import...
- Health & Medicine
Dendritic cell (DC) vaccines offer professional antigen presentation but are often limited by suboptimal trafficking to lymphoid tissues, whereas whole tumor cell vaccines preserve antigenic diversity yet frequently lack coordinated activation cues for efficient T cell priming. H...
- Health & MedicineOpen access
Traditional cognitive screening often relies on total scores, which can easily mask asynchronous impairment patterns across different cognitive domains. In particular, calculation ability, a sensitive indicator of executive function, is frequently misattributed to normal aging an...
- Health & MedicineOpen access
Postoperative recovery quality in laparoscopic surgery may benefit from deep neuromuscular blockade, whereas the effects of combining transversus abdominis plane block (TAPB) with moderate neuromuscular blockade in this regard remain unreported. This work investigated whether mod...
- Health & MedicineOpen access
BACKGROUND AND OBJECTIVES: Disease-related malnutrition (DRM) mandates routine screening in many nations to ensure quality care as nutritional status often deteriorates during hospitalization. This study aimed to establish tool-specific prevalence benchmarks at admission and disc...